论文部分内容阅读
目的:进一步探讨在新生儿感染性肺炎的治疗中应用盐酸氨溴索的实际价值。方法:选取连平县妇幼保健院2015年8月至2016年5月收治的80例新生儿感染性肺炎患儿,按临床随机表法平均列入观察组与对照组。对照组行常规治疗,观察组在对照组基础上加用盐酸氨溴索。观察两组患儿治疗有效率、症状缓解时间和住院时间,记录其不良反应的发生情况。结果:观察组的治疗有效率是92.5%,对照组的治疗有效率是75.0%,差异具有统计学意义(P<0.05);两组症状缓解时间和住院时间比较,差异具有统计学意义(P<0.01);两组患儿均不存在肝肾损害等严重不良反应。结论:在新生儿感染性肺炎的治疗中,盐酸氨溴索能够及时地缓解患儿的临床症状,提高治疗有效率,缩短住院时间,且具有一定的安全性。
Objective: To further explore the practical value of ambroxol hydrochloride in the treatment of neonatal infectious pneumonia. Methods: Eighty neonates with infectious pneumonia admitted to MCH from August 2015 to May 2016 in Lianping County were randomly divided into observation group and control group according to randomized clinical trial. Control group routine treatment, the observation group in the control group plus ambroxol hydrochloride. The treatment efficiency, symptom relief time and hospital stay in both groups were observed, and the incidence of adverse reactions was recorded. Results: The effective rate of treatment was 92.5% in the observation group and 75.0% in the control group, the difference was statistically significant (P <0.05). There was significant difference between the two groups in symptom relieving time and hospitalization time (P <0.01). There were no serious adverse reactions such as liver and kidney damage in both groups. Conclusion: In the treatment of neonatal pneumonia, ambroxol hydrochloride can relieve the clinical symptoms of children in time, improve the treatment efficiency, shorten the length of stay, and have some safety.